Nippon India NIFTY Pharma ETF
Monthly portfolio · 24 months through Aug-2026
compared to Jul-2026 · as on August 31,2026
Holdings
20
Scheme AUM
₹1,761 cr
New
0
Exited
0
Increased
20
Reduced
0
| Change | Security | Industry / Rating | Quantity | Δ Qty | % to NAV | Δ % | Market value |
|---|---|---|---|---|---|---|---|
| Increased | Sun Pharmaceutical Industries Limited INE044A01036 | Pharmaceuticals & Biotechnology | 18,40,784 | +31,424 | 20.75% | -0.54pp | ₹365 cr |
| Increased | Divi's Laboratories Limited INE361B01024 | Pharmaceuticals & Biotechnology | 2,20,941 | +3,766 | 11.88% | +1.54pp | ₹209 cr |
| Increased | Cipla Limited INE059A01026 | Pharmaceuticals & Biotechnology | 9,78,190 | +16,687 | 7.83% | -0.54pp | ₹138 cr |
| Increased | Laurus Labs Limited INE947Q01028 | Pharmaceuticals & Biotechnology | 6,76,401 | +11,543 | 7.36% | +0.22pp | ₹130 cr |
| Increased | Torrent Pharmaceuticals Limited INE685A01028 | Pharmaceuticals & Biotechnology | 2,54,999 | +4,371 | 7.34% | -0.25pp | ₹129 cr |
| Increased | Dr. Reddy's Laboratories Limited INE089A01031 | Pharmaceuticals & Biotechnology | 10,59,711 | +18,084 | 6.95% | -0.12pp | ₹122 cr |
| Increased | Lupin Limited INE326A01037 | Pharmaceuticals & Biotechnology | 4,22,174 | +7,190 | 5.25% | -0.68pp | ₹92.39 cr |
| Increased | Aurobindo Pharma Limited INE406A01037 | Pharmaceuticals & Biotechnology | 4,81,186 | +8,196 | 4.69% | +0.27pp | ₹82.62 cr |
| Increased | Glenmark Pharmaceuticals Limited INE935A01035 | Pharmaceuticals & Biotechnology | 2,61,749 | +4,458 | 3.69% | +0.29pp | ₹64.91 cr |
| Increased | Alkem Laboratories Limited INE540L01014 | Pharmaceuticals & Biotechnology | 1,01,737 | +1,745 | 3.08% | -0.32pp | ₹54.22 cr |
| Increased | Biocon Limited INE376G01013 | Pharmaceuticals & Biotechnology | 12,40,315 | +21,177 | 2.90% | -0.17pp | ₹51.1 cr |
| Increased | Zydus Lifesciences Limited INE010B01027 | Pharmaceuticals & Biotechnology | 4,34,941 | +7,444 | 2.87% | +0.02pp | ₹50.51 cr |
| Increased | IPCA Laboratories Limited INE571A01038 | Pharmaceuticals & Biotechnology | 2,41,488 | +4,142 | 2.71% | +0.26pp | ₹47.69 cr |
| Increased | Mankind Pharma Limited INE634S01028 | Pharmaceuticals & Biotechnology | 1,96,801 | +3,329 | 2.70% | -0.12pp | ₹47.61 cr |
| Increased | Gland Pharma Limited INE068V01023 | Pharmaceuticals & Biotechnology | 1,38,524 | +2,345 | 2.27% | +0.25pp | ₹39.98 cr |
| Increased | Sai Life Sciences Limited INE570L01029 | Pharmaceuticals & Biotechnology | 2,39,870 | +4,129 | 1.99% | +0.16pp | ₹35.01 cr |
| Increased | Wockhardt Limited INE049B01025 | Pharmaceuticals & Biotechnology | 1,43,561 | +2,445 | 1.54% | -0.09pp | ₹27.04 cr |
| Increased | Ajanta Pharma Limited INE031B01049 | Pharmaceuticals & Biotechnology | 73,229 | +1,314 | 1.50% | +0.03pp | ₹26.38 cr |
| Increased | Abbott India Limited INE358A01014 | Pharmaceuticals & Biotechnology | 9,055 | +149 | 1.33% | -0.13pp | ₹23.41 cr |
| Increased | Piramal Pharma Limited INE0DK501011 | Pharmaceuticals & Biotechnology | 10,81,282 | +18,485 | 1.32% | +0.09pp | ₹23.18 cr |
Cash & other
| Triparty Repo | 0.06% | ₹1.03 cr |
| Cash Margin - CCIL | 0.00% | ₹0.01 cr |
| Net Current Assets | -0.01% | ₹0 cr |